Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 3
1988 1
1992 1
1994 1
1996 1
1999 1
2005 1
2006 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
On the evolution of specificity and catalysis in subtilisin.
Wells JA, Cunningham BC, Graycar TP, Estell DA, Carter P. Wells JA, et al. Among authors: graycar tp. Cold Spring Harb Symp Quant Biol. 1987;52:647-52. doi: 10.1101/sqb.1987.052.01.074. Cold Spring Harb Symp Quant Biol. 1987. PMID: 3331349 No abstract available.
A beta-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy.
Harding FA, Liu AD, Stickler M, Razo OJ, Chin R, Faravashi N, Viola W, Graycar T, Yeung VP, Aehle W, Meijer D, Wong S, Rashid MH, Valdes AM, Schellenberger V. Harding FA, et al. Among authors: graycar t. Mol Cancer Ther. 2005 Nov;4(11):1791-800. doi: 10.1158/1535-7163.MCT-05-0189. Mol Cancer Ther. 2005. PMID: 16276001 Free article.
Altering the proteolytic activity of subtilisin through protein engineering.
Graycar TP, Bott RR, Caldwell RM, Dauberman JL, Lad PJ, Power SD, Sagar IH, Silva RA, Weiss GL, Woodhouse LR, et al. Graycar TP, et al. Ann N Y Acad Sci. 1992 Nov 30;672:71-9. doi: 10.1111/j.1749-6632.1992.tb35605.x. Ann N Y Acad Sci. 1992. PMID: 1476392 No abstract available.
12 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page